Bio-Rad Replaces its President and COO

Bio-Rad Laboratories Inc. has named Jon DiVincenzo as president and chief operating officer to succeed Andy Last, a five-year company veteran who retired (officially) earlier this week. Last began working for Bio-Rad in April 2019. 

“We are thrilled to welcome Jon DiVincenzo as our president and chief operating officer,” Bio-Rad Chairman/CEO Norman Schwartz said. “Jon brings to Bio-Rad over 30 years of industry experience across strategic, operational, and commercial organizations in both life science and clinical diagnostics. His extensive track record spans leadership roles in operations, marketing, and product development, which will be integral to our continued success.”
 
DiVincenzo joined Bio-Rad from Labcorp Holdings Inc., a global provider of comprehensive laboratory services, where he held various global operational and commercial leadership roles across the company’s several business units. Most recently, he was executive vice president and president, Central Laboratories and International. Prior to LabCorp, DiVincenzo was president of the Environmental Health Division at PerkinElmer, a global company focused on diagnostics, life science research, food quality, environmental health, and industrial testing. He also served as CEO of Enzymatics, a privately held molecular biology reagents company. Prior to that, DiVincenzo held roles of increasing responsibility in the Biosciences and Lab Water businesses of EMD Millipore, a subsidiary of Merck KGaA.

DiVincenzo earned a bachelor of science degree in mechanical engineering from Northeastern University.
 
“I am excited to join Bio-Rad and I look forward to working with the executive team to continue to make progress towards achieving the company’s long-term transformational and growth objectives,” DiVincenzo stated.
 
Bio-Rad Laboratories develops, manufactures, and markets products for the life science research and clinical diagnostics markets. Based in Hercules, Calif., Bio-Rad operates a global network of research, development, manufacturing, and sales operations with more than 7,700 employees, and $2.7 billion in revenues in 2023. Its customers include universities, research institutions, hospitals, food safety and environmental quality laboratories, and biopharmaceutical companies.